IMPACT OF STATIN THERAPY ON LDL REDUCTION AND ITS NUTRITIONAL IMPLICATIONS: A SYSTEMATIC   REVIEW

Lira Apriani Simbolon; Carissa Wityadarda; Bernadette Victoria; Nadia Amanda; Mayfa Yemima Simanjuntak; Syifha Nur Sallyima Rahardianti; Augustinus Lahagu; Prita Amelia Puspita Dewi

doi:10.14710/jnc.v15i1.49366

DOI: https://doi.org/10.14710/jnc.v15i1.49366

IMPACT OF STATIN THERAPY ON LDL REDUCTION AND ITS NUTRITIONAL IMPLICATIONS: A SYSTEMATIC REVIEW

Lira Apriani Simbolon, Carissa Wityadarda

, Bernadette Victoria, Nadia Amanda, Mayfa Yemima Simanjuntak, Syifha Nur Sallyima Rahardianti, Augustinus Lahagu, Prita Amelia Puspita Dewi

Department of Nutrition Science, Faculty of Health Science, Universitas Santo Borromeus Bandung, Jawa Barat, Indonesia

Received: 13 Mar 2025; Revised: 24 Jul 2025; Accepted: 23 Sep 2025; Available online: 28 Jan 2026; Published: 30 Jan 2026.

BibTex Citation Data :

@article{JNC49366,
    author = {Lira Simbolon and Carissa Wityadarda and Bernadette Victoria and Nadia Amanda and Mayfa Simanjuntak and Syifha Rahardianti and Augustinus Lahagu and Prita Dewi},
    title = {IMPACT OF STATIN THERAPY ON LDL REDUCTION AND ITS NUTRITIONAL IMPLICATIONS: A SYSTEMATIC   REVIEW},
    journal = {Journal of Nutrition College},
  volume = {15},
    number = {1},
    year = {2026},
    keywords = {LDL cholesterol; statins therapy; nutrition impact},
    abstract = {  ABSTRACT     Background   :   Elevated low-density lipoprotein (LDL) cholesterol is a major contributor to cardiovascular disease risk. Statins are widely prescribed as a first-line treatment to lower LDL levels, although treatment outcomes can vary based on drug combinations and the patient's nutritional status.     Objective:    This review aims to systematically assess the effectiveness of statin therapy in lowering LDL cholesterol and to explore the potential benefits of combination treatments and the role of nutrition in enhancing therapeutic outcomes.     Methods   : A systematic review was conducted using the PRISMA guidelines. Literature searches were performed on PubMed for the period between 2019 and 2024, focusing on clinical trials, randomized controlled trials, and meta-analyses involving human subjects. After screening and eligibility assessments, seven studies were included in the final analysis.     Results:    Statins were consistently found to reduce LDL cholesterol and lower the risk of cardiovascular events. Combination therapies, including statins with ezetimibe, omega-3 fatty acids, or fenofibrate, yielded superior outcomes compared to monotherapy. Rosuvastatin demonstrated greater LDL-lowering potential than atorvastatin, though with a slightly increased risk of diabetes. Moreover, nutritional factors—such as adequate fiber intake, healthy fats, and micronutrients like vitamin D and magnesium—were shown to support and potentially enhance the effectiveness of statin treatment.     Conclusion:    Statin therapy, whether used alone or in combination with other agents, is effective in managing LDL cholesterol and preventing cardiovascular disease. Integrating pharmacological treatment with personalized nutritional strategies may further improve therapeutic success and long-term health outcomes in patients with dyslipidemia.     Keywords:    LDL cholesterol; statins therapy; nutrition impact  },
   issn = {2622-884X},  doi = {10.14710/jnc.v15i1.49366},
    url = {https://ejournal3.undip.ac.id/index.php/jnc/article/view/49366}
}

Citation Format:

Abstract

ABSTRACT

Background: Elevated low-density lipoprotein (LDL) cholesterol is a major contributor to cardiovascular disease risk. Statins are widely prescribed as a first-line treatment to lower LDL levels, although treatment outcomes can vary based on drug combinations and the patient's nutritional status.

Objective: This review aims to systematically assess the effectiveness of statin therapy in lowering LDL cholesterol and to explore the potential benefits of combination treatments and the role of nutrition in enhancing therapeutic outcomes.

Methods: A systematic review was conducted using the PRISMA guidelines. Literature searches were performed on PubMed for the period between 2019 and 2024, focusing on clinical trials, randomized controlled trials, and meta-analyses involving human subjects. After screening and eligibility assessments, seven studies were included in the final analysis.

Results: Statins were consistently found to reduce LDL cholesterol and lower the risk of cardiovascular events. Combination therapies, including statins with ezetimibe, omega-3 fatty acids, or fenofibrate, yielded superior outcomes compared to monotherapy. Rosuvastatin demonstrated greater LDL-lowering potential than atorvastatin, though with a slightly increased risk of diabetes. Moreover, nutritional factors—such as adequate fiber intake, healthy fats, and micronutrients like vitamin D and magnesium—were shown to support and potentially enhance the effectiveness of statin treatment.

Conclusion: Statin therapy, whether used alone or in combination with other agents, is effective in managing LDL cholesterol and preventing cardiovascular disease. Integrating pharmacological treatment with personalized nutritional strategies may further improve therapeutic success and long-term health outcomes in patients with dyslipidemia.

Keywords: LDL cholesterol; statins therapy; nutrition impact

Fulltext View|Download

Keywords: LDL cholesterol; statins therapy; nutrition impact

Article Metrics:

Article Info

Section: Articles

Language : EN

In Vol 15, No 1 (2026): Januari (Issue In Progress)

Recent articles

EFEK VITAMIN D TERHADAP KADAR HbA1c PADA T2DM : NARATIF REVIEW HUBUNGAN ASUPAN YODIUM DENGAN KEJADIAN STUNTING PADA BALITA: LITERATURE REVIEW PERAN DIETARY INFLAMMATORY INDEX DAN KOMPOSISI LEMAK TUBUH DALAM MENINGKATKAN KADAR TNF ALPHA PADA INDIVIDU OBESITAS: TINJAUAN NARATIF More recent articles

Sutikno E, Tuna H, Syahadah AB. HUBUNGAN KADAR NATRIUM DENGAN KADAR LDL (Low Density Lipoprotein) PADA LANSIA. Cross-border. 2023;6(1):720–3
Pappan N, Awosika AO, Anis R. Dyslipidemia Continuing Education Activity [Internet]. 2024 Mar. Available from: https://www.ncbi.nlm.nih.gov/books/NBK560891/?report=printable
Hasan R. Studi Interaksi Obat Antihiperlipidemia Pada Pasien Rawat Jalan RSUD dr. M.M. Dunda Limboto. Jurnal Farmasi Tinctura. 2021;3(1):15–24
Udin B, Kholifah E. Literature Review: Mekanisme Kerja Obat Antidislipidemia. Jurnal Ilmiah Bakti Farmasi. 2021;6(1):35–44
Hsu HY, Lin CJ, Lee YS, Wu TH, Chien KL. Efficacy of more intensive lipid-lowering therapy on cardiovascular diseases: A systematic review and meta-analysis. Vol. 20, BMC Cardiovascular Disorders. BioMed Central; 2020
Haegele M, Djurdjevic A, Jordan F, Liu YC, Mildner L, Frey S, et al. Achievement of Low-Density Lipoprotein Cholesterol Targets in Cardiac Rehabilitation: Impact of the 2019 ESC/EAS Dyslipidaemia Guidelines. J Clin Med. 2022 Dec 1;11(23)
Pirillo A, Catapano AL. Statins increase Lp(a) plasma level: Is this clinically relevant? Vol. 41, European Heart Journal. Oxford University Press; 2020. p. 2285–7
Ako J, Yokote K, Tsujita K, Tanigawa R, Kamei R, Suganami H. Long-term Efficacy and Safety of K-924 Pitavastatin/Ezetimibe Fixed-dose Combination in Patients with Hypercholesterolemia: A Phase III, Multi-center, Open-label Trial. J Atheroscler Thromb. 2024;31(3):288–305
Sakuma M, Iimuro S, Shinozaki T, Kimura T, Nakagawa Y, Ozaki Y, et al. Optimal target of LDL cholesterol level for statin treatment: challenges to monotonic relationship with cardiovascular events. BMC Med. 2022 Dec 1;20(1)
Nakano Y, Yamamoto M, Matoba T, Katsuki S, Nakashiro S, Takase S, et al. Association between Serum Oxysterols and Coronary Plaque Regression during Lipid-Lowering Therapy with Statin and Ezetimibe: Insights from the CuVIC Trial. J Atheroscler Thromb. 2023;30(8):907–18
Jun JE, Jeong IK, Yu JM, Kim SR, Lee IK, Han KA, et al. Efficacy and Safety of Omega-3 Fatty Acids in Patients Treated with Statins for Residual Hypertriglyceridemia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Diabetes Metab J. 2020 Feb 1;44(1):78–90
Lee YJ, Hong SJ, Kang WC, Hong BK, Lee JY, Lee JB, et al. Rosuvastatin versus atorvastatin treatment in adults with coronary artery disease: secondary analysis of the randomised LODESTAR trial. BMJ. 2023 Oct 18;383:e075837
Ihm SH, Chung WB, Lee JM, Hwang BH, Yoo KD, Her SH, et al. Efficacy and Tolerability of Pitavastatin Versus Pitavastatin/Fenofibrate in High-risk Korean Patients with Mixed Dyslipidemia: A Multicenter, Randomized, Double-blinded, Parallel, Therapeutic Confirmatory Clinical Trial. Clin Ther. 2020 Oct 1;42(10):2021-2035.e3
Masana L, Ibarretxe D, Plana N. Reasons Why Combination Therapy Should Be the New Standard of Care to Achieve the LDL-Cholesterol Targets: Lipid-lowering combination therapy. Vol. 22, Current Cardiology Reports. Springer; 2020 Aug
Blom DJ, Almahmeed W, Al-Rasadi K, Azuri J, Daclin V, Kayikcioglu M, et al. Low-density l ipoprotein cholesterol goal achievement in patients with familial hypercholesterolemia in countries outside Western Europe: The International ChoLesterol management Practice Study. J Clin Lipidol. 2019 Jul 1;13(4):594–600
Djuricic I, Calder PC. Omega-3 (n-3) Fatty Acid-Statin Interaction: Evidence for a Novel Therapeutic Strategy for Atherosclerotic Cardiovascular Disease. Vol. 16, Nutrients. 2024
Warren T, McAllister R, Morgan A, Rai TS, McGilligan V, Ennis M, et al. The interdependency and co-regulation of the vitamin D and cholesterol metabolism. Vol. 10, Cells. MDPI; 2021
Nartea R, Mitoiu BI, Ghiorghiu I. The Link between Magnesium Supplements and Statin Medication in Dyslipidemic Patients. Vol. 45, Current Issues in Molecular Biology. Multidisciplinary Digital Publishing Institute (MDPI); 2023. p. 3146–67
Cammisotto V, Nocella C, Bartimoccia S, Sanguigni V, Francomano D, Sciarretta S, et al. The role of antioxidants supplementation in clinical practice: focus on cardiovascular risk factors. Vol. 10, Antioxidants. MDPI; 2021. p. 1–32
Motkowski R, Maciejczyk M, Hryniewicka M, Karpińska J, Mikołuć B. Effect of Statin Therapy on the Plasma Concentrations of Retinol, Alpha-Tocopherol and Coenzyme Q10 in Children with Familial Hypercholesterolemia. Cardiovasc Drugs Ther. 2022 Feb 1;36(1):75–84

Last update:

No citation recorded.

Last update:

No citation recorded.

The Authors submitting a manuscript do so on the understanding that if accepted for publication, copyright of the article shall be assigned to Journal of Nutrition College and Department of Nutrition Science, Faculty of Medicine, Universitas Diponegoro as publisher of the journal.

Copyright encompasses exclusive rights to reproduce and deliver the article in all form and media, including reprints, photographs, microfilms and any other similar reproductions, as well as translations. The reproduction of any part of this journal, its storage in databases and its transmission by any form or media, such as electronic, electrostatic and mechanical copies, photocopies, recordings, magnetic media, etc., will be allowed only with a written permission from Journal of Nutrition College.

Journal of Nutrition College, Faculty of Medicine, Universitas Diponegoro, the Editors and the Advisory Editorial Board make every effort to ensure that no wrong or misleading data, opinions or statements be published in the journal. In any way, the contents of the articles and advertisements published in Journal of Nutrition College are sole and exclusive responsibility of their respective authors and advertisers.